MXPA05005315A - Dispositivos medicos que incorporan rapamicina deuterizada para la administracion controlada de la misma. - Google Patents
Dispositivos medicos que incorporan rapamicina deuterizada para la administracion controlada de la misma.Info
- Publication number
- MXPA05005315A MXPA05005315A MXPA05005315A MXPA05005315A MXPA05005315A MX PA05005315 A MXPA05005315 A MX PA05005315A MX PA05005315 A MXPA05005315 A MX PA05005315A MX PA05005315 A MXPA05005315 A MX PA05005315A MX PA05005315 A MXPA05005315 A MX PA05005315A
- Authority
- MX
- Mexico
- Prior art keywords
- rapamycin
- deuterated
- medical devices
- controlled delivery
- devices incorporating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Abstract
La rapamicina deuterizada puede introducirse controlablemente a las ubicaciones objetivo del cuerpo del paciente al utilizar un dispositivo medico implantable que tienen una estructura incorporada con un agente terapeutico que comprende la rapamicina deuterizada. Las rapamicinas deuterizadas representativas incluyen epi-7-deuterometil rapamicina, 7,43-d6 rapamicina, 7-deuterometil rapamicina y 31,42-d2-rapamicina e isomeros de los mismos y mezclas de los mismos. La rapamicina deuterizada tambien puede ser glicosilada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/301,504 US6884429B2 (en) | 1997-09-05 | 2002-11-20 | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
PCT/US2003/036838 WO2004045668A1 (en) | 2002-11-20 | 2003-11-17 | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05005315A true MXPA05005315A (es) | 2005-10-26 |
Family
ID=32324552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05005315A MXPA05005315A (es) | 2002-11-20 | 2003-11-17 | Dispositivos medicos que incorporan rapamicina deuterizada para la administracion controlada de la misma. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6884429B2 (es) |
EP (1) | EP1562654A1 (es) |
JP (1) | JP2006512943A (es) |
KR (1) | KR20050071702A (es) |
AU (1) | AU2003287677A1 (es) |
BR (1) | BR0315700A (es) |
CA (1) | CA2505080A1 (es) |
MX (1) | MXPA05005315A (es) |
NZ (1) | NZ539470A (es) |
TW (1) | TWI293253B (es) |
WO (1) | WO2004045668A1 (es) |
Families Citing this family (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US8236048B2 (en) * | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
AU2002345328A1 (en) | 2001-06-27 | 2003-03-03 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US6981977B2 (en) * | 2001-10-26 | 2006-01-03 | Atrium Medical Corporation | Body fluid cartridge exchange platform device |
ES2354605T3 (es) * | 2003-02-21 | 2011-03-16 | Sorin Biomedica Cardio S.R.L. | Procedimiento de producción de stents y el stent correspondiente. |
JP2006523235A (ja) * | 2003-03-28 | 2006-10-12 | コーザン バイオサイエンシス インコーポレイテッド | 再狭窄を予防するための装置、方法及び組成物 |
US7160867B2 (en) * | 2003-05-16 | 2007-01-09 | Isotechnika, Inc. | Rapamycin carbohydrate derivatives |
US7488343B2 (en) * | 2003-09-16 | 2009-02-10 | Boston Scientific Scimed, Inc. | Medical devices |
US8137397B2 (en) * | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
US7563780B1 (en) * | 2004-06-18 | 2009-07-21 | Advanced Cardiovascular Systems, Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US8236338B2 (en) | 2004-07-13 | 2012-08-07 | The University Of Tennessee Research Foundation | Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts |
US8962023B2 (en) | 2004-09-28 | 2015-02-24 | Atrium Medical Corporation | UV cured gel and method of making |
US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
WO2006036967A1 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
WO2006036970A2 (en) * | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Method of thickening a coating using a drug |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
EP1898834A4 (en) * | 2005-06-20 | 2010-12-15 | Abbeymoor Medical Inc | SELF-ADJUSTABLE ENDO-URETRAL DEVICE AND METHODS OF USE |
JP5289951B2 (ja) * | 2005-07-26 | 2013-09-11 | タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 同位体置換されたパントプラゾール |
KR101358509B1 (ko) * | 2005-07-26 | 2014-02-05 | 다케다 게엠베하 | 동위 원소 치환된 양성자 펌프 억제제 |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
CA2624179A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
CA2626030A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
WO2007056175A2 (en) * | 2005-11-04 | 2007-05-18 | Wyeth | 41-methoxy isotope labeled rapamycin 42-ester |
CN101340859B (zh) * | 2005-11-17 | 2010-12-15 | 路嘉株式会社 | 用于制备在对身体的医疗手术中使用的插入物的方法 |
DK1954669T3 (en) | 2005-12-01 | 2015-10-12 | Auspex Pharmaceuticals Inc | SUBSTITUTED phenethylamines a serotonergic AND / OR NOREPINEPHRINERG ACTIVITY |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US20080082036A1 (en) * | 2006-04-25 | 2008-04-03 | Medtronic, Inc. | Cerebrospinal fluid shunt having long term anti-occlusion agent delivery |
WO2007140189A2 (en) * | 2006-05-26 | 2007-12-06 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted carboxylic acid compounds |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
EP2032091A2 (en) | 2006-06-29 | 2009-03-11 | Boston Scientific Limited | Medical devices with selective coating |
JP2009545407A (ja) * | 2006-08-02 | 2009-12-24 | ボストン サイエンティフィック サイムド,インコーポレイテッド | 三次元分解制御を備えたエンドプロテーゼ |
ATE508708T1 (de) | 2006-09-14 | 2011-05-15 | Boston Scient Ltd | Medizinprodukte mit wirkstofffreisetzender beschichtung |
JP2010503485A (ja) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | 医療用デバイスおよび同デバイスの製造方法 |
ES2368125T3 (es) | 2006-09-15 | 2011-11-14 | Boston Scientific Scimed, Inc. | Endoprótesis bioerosionable con capas inorgánicas bioestables. |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
JP2010503490A (ja) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | 調整可能な表面特徴を備えた内部人工器官 |
ATE517590T1 (de) | 2006-09-15 | 2011-08-15 | Boston Scient Ltd | Biologisch erodierbare endoprothesen |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
CA2703011A1 (en) * | 2006-10-23 | 2008-10-23 | Concert Pharmaceuticals Inc. | Oxazolidinone derivatives and methods of use |
WO2008057344A2 (en) | 2006-11-06 | 2008-05-15 | Atrium Medical Corporation | Coated surgical mesh |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
ATE488259T1 (de) | 2006-12-28 | 2010-12-15 | Boston Scient Ltd | Bioerodierbare endoprothesen und herstellungsverfahren dafür |
US8221496B2 (en) * | 2007-02-01 | 2012-07-17 | Cordis Corporation | Antithrombotic and anti-restenotic drug eluting stent |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
ES2395241T3 (es) * | 2007-03-07 | 2013-02-11 | Concert Pharmaceuticals Inc. | Derivados deuterados de piperazina como compuestos antianginosos |
EP3103790B1 (en) | 2007-03-15 | 2018-05-09 | Auspex Pharmaceuticals, Inc. | Substituted phenethylamine with serotoninergic and/or norepinephrinergic activity |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
CN101687868B (zh) * | 2007-05-01 | 2012-12-12 | 康塞特医药品公司 | 吗啡烷化合物 |
FI3825306T3 (fi) | 2007-05-01 | 2023-08-23 | Concert Pharmaceuticals Inc | Morfinaaniyhdisteitä |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
JP2010529994A (ja) * | 2007-06-13 | 2010-09-02 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 置換ピペラジン |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
EP2187988B1 (en) | 2007-07-19 | 2013-08-21 | Boston Scientific Limited | Endoprosthesis having a non-fouling surface |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
WO2009018340A2 (en) | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
WO2009020520A1 (en) | 2007-08-03 | 2009-02-12 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8142490B2 (en) | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
JP2011503231A (ja) * | 2007-11-20 | 2011-01-27 | コンサート ファーマシューティカルズ インコーポレイテッド | Hcv感染処置のためのペプチド |
US7833266B2 (en) * | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
EP2242493B1 (en) * | 2008-01-22 | 2013-06-05 | Concert Pharmaceuticals Inc. | Derivatives of gefitinib |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) * | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP2303350A2 (en) | 2008-06-18 | 2011-04-06 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
TWI523652B (zh) * | 2008-07-15 | 2016-03-01 | 泰瑞克公司 | 氘化苄基苯衍生物及使用方法 |
US7951193B2 (en) * | 2008-07-23 | 2011-05-31 | Boston Scientific Scimed, Inc. | Drug-eluting stent |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
EP2403546A2 (en) | 2009-03-02 | 2012-01-11 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
AU2010249558A1 (en) * | 2009-05-20 | 2011-12-08 | Arsenal Medical, Inc. | Medical implant |
US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
US8888840B2 (en) * | 2009-05-20 | 2014-11-18 | Boston Scientific Scimed, Inc. | Drug eluting medical implant |
US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US8372133B2 (en) * | 2009-10-05 | 2013-02-12 | 480 Biomedical, Inc. | Polymeric implant delivery system |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
CA2889981A1 (en) | 2012-10-29 | 2014-05-08 | Ariste Medical, Inc. | Polymer coating compositions and coated products |
KR102339132B1 (ko) * | 2013-03-15 | 2021-12-13 | 타리스 바이오메디컬 엘엘씨 | 약물 전달 장치 및 약물 전달 방법 |
EP3666271A1 (en) | 2013-12-03 | 2020-06-17 | Intra-Cellular Therapies, Inc. | Miscrospheres comprising a plga matrix for medical use |
EP3125893B1 (en) * | 2014-04-04 | 2023-09-20 | Intra-Cellular Therapies, Inc. | Deuterated heterocycle fused gamma-carbolines as antagonists of 5-ht2a receptors |
WO2015164524A1 (en) | 2014-04-22 | 2015-10-29 | Ariste Medical, Inc. | Methods and processes for application of drug delivery polymeric coatings |
EP3628640B1 (en) * | 2014-09-02 | 2023-08-09 | Hub Therapeutics | Methods of making a deuterated or a non-deuterated molecule and pharmaceutical formulations for treatment |
EP3888656A1 (en) | 2016-03-25 | 2021-10-06 | Intra-Cellular Therapies, Inc. | Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder |
JP7013454B2 (ja) | 2016-10-12 | 2022-02-15 | イントラ-セルラー・セラピーズ・インコーポレイテッド | アモルファス固体分散体 |
MX2021013640A (es) | 2017-03-24 | 2022-08-31 | Intra Cellular Therapies Inc | Composiciones novedosas y metodos. |
CA3108558A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
BR112021003655A2 (pt) | 2018-08-31 | 2021-05-18 | Intra-Cellular Therapies, Inc. | métodos novos |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994117A (en) * | 1986-08-13 | 1991-02-19 | Fehder Carl G | Quantitative carbon dioxide detector |
US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
US5288711A (en) * | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
US5885248A (en) * | 1994-02-22 | 1999-03-23 | Wolf Tory Medical, Inc. | Intubation detection system with transducer based indicator |
KR20040068613A (ko) | 1994-03-25 | 2004-07-31 | 이소테크니카 인코포레이티드 | 중수소화된 화합물 이를 포함하는 고혈압 치료용 조성물 |
US5785051A (en) * | 1996-06-21 | 1998-07-28 | University Of Rochester | Signal generating endotracheal tube apparatus |
US5749358A (en) * | 1996-10-10 | 1998-05-12 | Nellcor Puritan Bennett Incorporated | Resuscitator bag exhaust port with CO2 indicator |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
US6342507B1 (en) * | 1997-09-05 | 2002-01-29 | Isotechnika, Inc. | Deuterated rapamycin compounds, method and uses thereof |
US6890546B2 (en) * | 1998-09-24 | 2005-05-10 | Abbott Laboratories | Medical devices containing rapamycin analogs |
US6153252A (en) * | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
US6335029B1 (en) * | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
US6584974B1 (en) * | 2001-12-07 | 2003-07-01 | Mercury Enterprises, Inc. | Patient esophageal detector device in combination with a carbon dioxide detector |
-
2002
- 2002-11-20 US US10/301,504 patent/US6884429B2/en not_active Expired - Fee Related
-
2003
- 2003-11-06 TW TW092131045A patent/TWI293253B/zh active
- 2003-11-17 NZ NZ539470A patent/NZ539470A/en unknown
- 2003-11-17 AU AU2003287677A patent/AU2003287677A1/en not_active Abandoned
- 2003-11-17 WO PCT/US2003/036838 patent/WO2004045668A1/en not_active Application Discontinuation
- 2003-11-17 MX MXPA05005315A patent/MXPA05005315A/es unknown
- 2003-11-17 EP EP03781978A patent/EP1562654A1/en not_active Withdrawn
- 2003-11-17 KR KR1020057008961A patent/KR20050071702A/ko not_active Application Discontinuation
- 2003-11-17 BR BR0315700-8A patent/BR0315700A/pt not_active IP Right Cessation
- 2003-11-17 CA CA002505080A patent/CA2505080A1/en not_active Abandoned
- 2003-11-17 JP JP2004553885A patent/JP2006512943A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TW200418538A (en) | 2004-10-01 |
TWI293253B (en) | 2008-02-11 |
NZ539470A (en) | 2006-11-30 |
US20030130206A1 (en) | 2003-07-10 |
CA2505080A1 (en) | 2004-06-03 |
US6884429B2 (en) | 2005-04-26 |
WO2004045668A1 (en) | 2004-06-03 |
JP2006512943A (ja) | 2006-04-20 |
EP1562654A1 (en) | 2005-08-17 |
BR0315700A (pt) | 2005-09-06 |
AU2003287677A1 (en) | 2004-06-15 |
KR20050071702A (ko) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05005315A (es) | Dispositivos medicos que incorporan rapamicina deuterizada para la administracion controlada de la misma. | |
AU2003220312A1 (en) | Patient controlled activation with implantable drug delivery devices | |
EP2522319A3 (en) | Implantable drug delivery system | |
MXPA03003869A (es) | Dispositivos medicos revestidos. | |
MXPA03006825A (es) | Dispositivos vasculares revestidos. | |
AU9486901A (en) | Coated medical devices | |
EP2407203A3 (en) | Solid therapeutic agent for use in an implantable drug delivery device | |
WO2004010975A3 (en) | Controlled drug delivery | |
AU2003287734A1 (en) | Implantable device for delivering cardiac drug therapy | |
ATE416798T1 (de) | Medizinprodukt mit gewebeabhängiger arzneimittelelution | |
WO2005048850A3 (en) | Systems and methods relating to associating a medical implant with a delivery device | |
WO2006037049A3 (en) | Application of a coating on a medical device | |
AU2003241515A1 (en) | Drug eluting implantable medical device | |
WO2001043749A3 (en) | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration | |
WO2003009884A3 (en) | Elongated syringe | |
WO2004091444A3 (en) | Implantable medical device comprising therapeutic agents with different diffusion rates | |
EP2196226A3 (en) | Coated medical devices | |
PL1543851T3 (pl) | Wszczepialne urządzenie do podawania substancji czynnej | |
DE60124286D1 (de) | Beschichtete medizinische geräte | |
WO2004087011A3 (en) | Therapeutic agent delivery device with controlled therapeutic agent release rates | |
CA2332368A1 (en) | A medical apparatus for use by a patient for medical self treatment of diabetes | |
AU2003284018A1 (en) | Medical device for neural stimulation and controlled drug delivery | |
WO2005011769A3 (en) | Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent | |
WO1995028124A3 (en) | An adjunctive polymer system for use with medical device | |
AU2001268963A1 (en) | Apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same |